495 related articles for article (PubMed ID: 30055563)
21. A TLR4 agonist synergizes with dendritic cell-directed lentiviral vectors for inducing antigen-specific immune responses.
Xiao L; Kim J; Lim M; Dai B; Yang L; Reed SG; Baltimore D; Wang P
Vaccine; 2012 Mar; 30(15):2570-81. PubMed ID: 22314134
[TBL] [Abstract][Full Text] [Related]
22. Powerful Complex Immunoadjuvant Based on Synergistic Effect of Combined TLR4 and NOD2 Activation Significantly Enhances Magnitude of Humoral and Cellular Adaptive Immune Responses.
Tukhvatulin AI; Dzharullaeva AS; Tukhvatulina NM; Shcheblyakov DV; Shmarov MM; Dolzhikova IV; Stanhope-Baker P; Naroditsky BS; Gudkov AV; Logunov DY; Gintsburg AL
PLoS One; 2016; 11(5):e0155650. PubMed ID: 27187797
[TBL] [Abstract][Full Text] [Related]
23. Targeting poly(I:C) to the TLR3-independent pathway boosts effector CD8 T cell differentiation through IFN-alpha/beta.
Ngoi SM; Tovey MG; Vella AT
J Immunol; 2008 Dec; 181(11):7670-80. PubMed ID: 19017955
[TBL] [Abstract][Full Text] [Related]
24. Targeting interferon-alpha to dendritic cells enhances a CD8
Graham JP; Authie P; Karolina Palucka A; Zurawski G
Vaccine; 2017 Aug; 35(35 Pt B):4532-4539. PubMed ID: 28743486
[TBL] [Abstract][Full Text] [Related]
25. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
Loré K; Betts MR; Brenchley JM; Kuruppu J; Khojasteh S; Perfetto S; Roederer M; Seder RA; Koup RA
J Immunol; 2003 Oct; 171(8):4320-8. PubMed ID: 14530357
[TBL] [Abstract][Full Text] [Related]
26. AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity.
Didierlaurent AM; Morel S; Lockman L; Giannini SL; Bisteau M; Carlsen H; Kielland A; Vosters O; Vanderheyde N; Schiavetti F; Larocque D; Van Mechelen M; Garçon N
J Immunol; 2009 Nov; 183(10):6186-97. PubMed ID: 19864596
[TBL] [Abstract][Full Text] [Related]
27. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
[TBL] [Abstract][Full Text] [Related]
28. CNL, a ricin B-like lectin from mushroom Clitocybe nebularis, induces maturation and activation of dendritic cells via the toll-like receptor 4 pathway.
Svajger U; Pohleven J; Kos J; Strukelj B; Jeras M
Immunology; 2011 Dec; 134(4):409-18. PubMed ID: 22044067
[TBL] [Abstract][Full Text] [Related]
29. A recombinant Bacille Calmette-Guérin construct expressing the Plasmodium falciparum circumsporozoite protein enhances dendritic cell activation and primes for circumsporozoite-specific memory cells in BALB/c mice.
Arama C; Waseem S; Fernández C; Assefaw-Redda Y; You L; Rodriguez A; Radošević K; Goudsmit J; Kaufmann SH; Reece ST; Troye-Blomberg M
Vaccine; 2012 Aug; 30(37):5578-84. PubMed ID: 21983157
[TBL] [Abstract][Full Text] [Related]
30. Mycobacterium bovis bacillus Calmette-Guérin-infected dendritic cells potently activate autologous T cells via a B7 and interleukin-12-dependent mechanism.
Cheadle EJ; Selby PJ; Jackson AM
Immunology; 2003 Jan; 108(1):79-88. PubMed ID: 12519306
[TBL] [Abstract][Full Text] [Related]
31. The effect of Toll-like receptor agonists on the immunogenicity of MVA-SARS-2-S vaccine after intranasal administration in mice.
Do KTH; Willenzon S; Ristenpart J; Janssen A; Volz A; Sutter G; Förster R; Bošnjak B
Front Cell Infect Microbiol; 2023; 13():1259822. PubMed ID: 37854858
[TBL] [Abstract][Full Text] [Related]
32. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4.
Doyle SE; O'Connell R; Vaidya SA; Chow EK; Yee K; Cheng G
J Immunol; 2003 Apr; 170(7):3565-71. PubMed ID: 12646618
[TBL] [Abstract][Full Text] [Related]
33. Toll-like receptor agonist combinations augment mouse T-cell anti-tumor immunity via IL-12- and interferon ß-mediated suppression of immune checkpoint receptor expression.
Jeon D; McNeel DG
Oncoimmunology; 2022; 11(1):2054758. PubMed ID: 35340661
[TBL] [Abstract][Full Text] [Related]
34. CD40 engagement enhances antigen-presenting langerhans cell priming of IFN-gamma-producing CD4+ and CD8+ T cells independently of IL-12.
Gorbachev AV; Fairchild RL
J Immunol; 2004 Aug; 173(4):2443-52. PubMed ID: 15294958
[TBL] [Abstract][Full Text] [Related]
35. CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1
Yamauchi T; Hoki T; Oba T; Kajihara R; Attwood K; Cao X; Ito F
Cancer Immunol Immunother; 2022 Jan; 71(1):137-151. PubMed ID: 34037810
[TBL] [Abstract][Full Text] [Related]
36. Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen.
Tüting T; Gambotto A; Robbins PD; Storkus WJ; DeLeo AB
Gene Ther; 1999 Apr; 6(4):629-36. PubMed ID: 10476222
[TBL] [Abstract][Full Text] [Related]
37. Marina crystal minerals (MCM) activate human dendritic cells to induce CD4+ and CD8+ T cell responses in vitro.
Ghoneum MH; Ogura T; Gimzewski JK; Ghoneum AD; Henary MC; Agrawal S
Int J Immunopathol Pharmacol; 2018; 32():2058738418797768. PubMed ID: 30270704
[TBL] [Abstract][Full Text] [Related]
38. Combination of TLR8 and TLR4 agonists reduces the degrading effects of nicotine on DC-NK mediated effector T cell generation.
Nouri-Shirazi M; Tamjidi S; Nourishirazi E; Guinet E
Int Immunopharmacol; 2018 Aug; 61():54-63. PubMed ID: 29803914
[TBL] [Abstract][Full Text] [Related]
39. Expression of Toll-like receptors and costimulatory molecules in splenic B cells in a normal and abortion-prone murine pregnancy model.
Lorek D; Kedzierska AE; Slawek A; Chelmonska-Soyta A
Am J Reprod Immunol; 2019 Aug; 82(2):e13148. PubMed ID: 31134706
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of cytokine synergy essential for vaccine protection against viral challenge.
Ahlers JD; Belyakov IM; Matsui S; Berzofsky JA
Int Immunol; 2001 Jul; 13(7):897-908. PubMed ID: 11431420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
